Arebi, Naila

East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort

Burisch, J., Pedersen, N., Čuković-Čavka, S., Brinar, M., Kaimakliotis, I., Duricova, D., Shonová, O., Vind, I., Avnstrøm, S., Thorsgaard, N., et al. (2014) · Gut

Inflammatory Bowel DiseaseOcular Diseases and Behçet’s Syndrome

Cited by 429

Accuracy of information given by ChatGPT for patients with inflammatory bowel disease in relation to ECCO guidelines

Sciberras, M., Farrugia, Y., Gordon, H., Furfaro, F., Allocca, M., Torres, J., Arebi, N., Fiorino, G., Iacucci, M., Verstockt, B., et al. (2024) · Journal of Crohn's and Colitis

Artificial Intelligence in Healthcare and EducationArtificial Intelligence in Healthcare

Cited by 45

Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm

Panoskaltsis, N., McCarthy, N. E., Stagg, A. J., Mummery, C. J., Husni, M., Arebi, N., Greenstein, D., Price, C. L., Al-Hassi, H. O., Koutinas, M., et al. (2021) · Cancer Immunology, Immunotherapy

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 16

UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation

Yiannakou, Y., Agrawal, A., Allen, P. B., Arebi, N., Brown, S. R., Eugenicos, M. P., Farmer, A. D., McLain-Smith, S., McLaughlin, J., Sanders, D. S., et al. (2018) · Therapeutic Advances in Gastroenterology

Gastrointestinal motility and disordersInflammatory Bowel Disease

Cited by 12